BioAdaptives Launches MyndSystem Platform for Cognitive Performance and Recovery

BioAdaptives, Inc. (OTCMKTS: BDPT) has announced the launch of MyndSystem, a dual-phase cognitive support platform designed to enhance mental performance and recovery. The platform features MyndMed for daytime focus and clarity, and MyndRenew for nighttime sleep and neurological restoration, alongside a dedicated website to facilitate direct-to-consumer sales.

The system is intended to address brain function across active and restorative cycles, targeting focus, clarity and stress resilience during the day while promoting sleep quality and neurological recovery at night. According to the company, the platform is positioned as a long-term growth driver. The announcement was made via a press release on InvestorWire.

BioAdaptives is known for developing science-driven health and wellness products. Through its ClearMynd division, the company focuses on cognitive performance, recovery, and enduring brain health. The MyndSystem platform represents a significant step in this direction, offering a comprehensive approach to cognitive wellness.

The launch comes as the company seeks to expand its presence in the cognitive health market, which is seeing growing consumer interest in products that support mental acuity and sleep quality. By offering a dual-phase solution, BioAdaptives aims to differentiate itself from single-purpose supplements.

More information about the company and its products can be found on its website at www.bioadaptives.com. The company also utilizes InvestorWire for press release distribution and corporate communications.